The Swabs Collection Kits Market is expected to grow with the CAGR of 5.1% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.
North America Swabs Collection Kits Market is a highly consolidated market which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in North America swabs collection kits market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition and agreement into the market. This has helped companies to maximize the sales with enhanced product portfolio. For instance, in August 2020, GeneDx, Inc. announced the launch of GenomeXpress, a rapid genome sequencing test. The test is used to identify variations in any part of the gene. With this new launch, the company is likely to grow in coming years.
Puritan Medical Products is the dominating player in the North America swabs collection kits market. The other players included in the swabs collection kits market are Quidel Corporation, DiaSorin Molecular LLC, Medline Industries, Inc., Starplex Scientific Inc., GeneDx, Inc., BD, COPAN Diagnostics Inc., BTNX Inc., Norgen Biotek Corp., Thermo Fisher Scientific Inc., Hologic, Inc., Path-Tec, LLC, Quest Diagnostics Incorporated, Hardy Diagnostics among others.
Puritan Medical Products is headquartered in Maine, U.S. and was founded in 1919. The company is engaged in the manufacturing of swabs kit among other products to deliver innovative solutions for even the most demanding applications. The company is providing products under categories such as controlled environments, diagnostics/specimen collection, environmental, forensics/genetics, microbiology media and medical among which controlled environments, diagnostics/specimen collection, forensics/genetics and medical are the market focused categories.
The company has wide presence across North America, South America, Europe, Middle East and Africa and Asia-Pacific.
Thermo Fisher Scientific Inc.:
Thermo Fisher Scientific Inc. is headquartered in Massachusetts, U.S. and was founded in 2006. The company is focused on making the world healthier, cleaner and safer by accelerating life science research, solving complex analytical challenges and improving patients’ therapies and diagnostics. The company deals in multiple business segments namely life science solutions, analytical instruments, specialty diagnostics and laboratory products and services among which specialty diagnostics is the market focused segment. The company is providing products under categories such as Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon out of which Thermo Scientific is the market focused category. The company is engaged in continuous development of swabs collection kits and related products.
The company has wide presence across Europe, North America and Asia-Pacific. The company has various subsidiaries such as Thermo Electron North America LLC (U.S.), Fisher Scientific GmbH (Germany), Fisher Scientific Korea Ltd (Korea), Thermo Fisher Scientific Germany BV & Co KG (Germany), Thermo Fisher Scientific K.K. (Japan) among others.
BD is headquartered in New Jersey, U.S. and was founded in 1897. The company is engaged in the development, manufacture and sale of broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions which also provide customer solutions that are focused on improving medication management and patient safety among others. The company deal in multiple business segments namely BD medical, BD life science and BD interventional among which BD life science is the market focused segment. The company is providing products under categories such as anaesthesia delivery, biopsy, biosciences, biosurgery, cervical cancer screening, diabetes care, drainage, drug delivery system, gastrointestinal care, hazardous drug safety, hernia repair and fixation, homecare, infection prevention, infusion therapy, interventional specialities, lab automation, medication and supply management, microbiology solution, molecular diagnostic, patient monitoring, prostrate health, respiratory care, sharp disposal solution, software solution, specimen collection, surgical instruments, syringes and needles, urology and kidney health, vascular access, vascular surgery and wound care out of which specimen collection is the market focused category.
The company has wide presence across North America, South America, Europe, Middle East and Africa and Asia-Pacific. The company has various subsidiaries such as Care Fusion (U.S.), C.R. Bard (U.S.), Accuri Cytometers Inc. (U.S.), Becton Dickson UK ltd. (U.K.) and Straub medical AG (Switzerland) among others.
Global Swabs Collection Kits Market – Industry Trends and Forecast to 2027
Europe Swabs Collection Kits Market – Industry Trends and Forecast to 2028
North America Swabs Collection Kits Market – Industry Trends and Forecast to 2028